Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies

被引:3
|
作者
Liao, Wei [1 ]
Sharma, Sanjai [1 ]
机构
[1] UCLA Sch Med, Greater Los Angeles VA Healthcare Ctr, Div Hematol Oncol, Los Angeles, CA USA
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE; BONE-MARROW; THERAPEUTIC TARGET; DOWN-REGULATION; EXPRESSION; ZAP-70; APOPTOSIS; OVEREXPRESSION; ERK;
D O I
10.20892/j.issn.2095-3941.2016.0026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) cells over-express a guanine exchange factor (GEF), Rasgrf-1. This GEF increases active Ras as it catalyzes the removal of GDP from Ras so that GTP can bind and activate Ras. This study aims to study the mechanism of action of Rasgrf-1 in B-cell malignancies. Methods: N-terminus truncated Rasgrf-1 variants have a higher GEF activity as compared to the full-length transcript therefore a MCL cell line with stable over-expression of truncated Rasgrf-1 was established. The B-cell receptor (BCR) and chemokine signaling pathways were compared in the Rasgrf-1 over-expressing and a control transfected cell line. Results: Cells over-expressing truncated form of Rasgrf-1 have a higher proliferative rate as compared to control transfected cells. BCR was activated by lower concentrations of anti-IgM antibody in Rasgrf-1 over-expressing cells as compared to control cells indicating that these cells are more sensitive to BCR signaling. BCR signaling also phosphorylates Rasgrf-1 that further increases its GEF function and amplifies BCR signaling. This activation of Rasgrf-1 in over-expressing cells resulted in a higher expression of phospho-ERK, AKT, BTK and PKC-alpha as compared to control cells. Besides BCR, Rasgrf-1 over-expressing cells were also more sensitive to microenvironment stimuli as determined by resistance to apoptosis, chemotaxis and ERK pathway activation. Conclusions: This GEF protein sensitizes B-cells to BCR and chemokine mediated signaling and also upregulates a number of other signaling pathways which promotes growth and survival of these cells.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [31] B-cell receptor signaling in lymphoid malignancies - oncogenic driver and therapeutic target
    Schmitt, C.
    Oncology Research and Treatment, 2015, 38 : 87 - 88
  • [32] B-cell tolerance to the B-cell receptor variable regions
    Jacobsen, Johanne T.
    Sundvold-Gjerstad, Vibeke
    Skjeldal, Frode M.
    Andersen, Jan-Terje
    Abrahamsen, Greger
    Bakke, Oddmund
    Spurkland, Anne
    Bogen, Bjarne
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (10) : 2577 - 2587
  • [33] TRANSMEMBRANE SIGNALING BY THE B-CELL ANTIGEN RECEPTOR
    PEAKER, CJG
    CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) : 359 - 363
  • [34] B-cell receptor signaling derailed in lymphomas
    Klein, Ulf
    Pasqualucci, Laura
    IMMUNOLOGY AND CELL BIOLOGY, 2010, 88 (04): : 346 - 347
  • [35] Rituximab inhibits B-cell receptor signaling
    Kheirallah, Samar
    Caron, Pierre
    Gross, Emilie
    Quillet-Mary, Anne
    Bertrand-Michel, Justine
    Fournie, Jean-Jacques
    Laurent, Guy
    Bezombes, Christine
    BLOOD, 2010, 115 (05) : 985 - 994
  • [36] B-cell receptor signalling in B-cell lymphoproliferative disorders
    Lazarian, Gregory
    Cymbalista, Florence
    HEMATOLOGIE, 2023, 29 : 5 - 13
  • [37] Chimeric Antigen Receptor Therapy for B-cell Malignancies
    Porter, David L.
    Kalos, Michael
    Zheng, Zhaohui
    Levine, Bruce
    June, Carl
    JOURNAL OF CANCER, 2011, 2 : 331 - 332
  • [38] B-Cell Receptor
    Brezski, Randall J.
    Monroe, John G.
    MULTICHAIN IMMUNE RECOGNITION RECEPTOR SIGNALING: FROM SPATIOTEMPORAL ORGANIZATION TO HUMAN DISEASE, 2008, 640 : 12 - 23
  • [39] B-cell activating factor receptor expression is associated with germinal center B-cell maintenance
    Josue Carrillo-Ballesteros, Francisco
    Oregon-Romero, Edith
    Antonio Franco-Topete, Ramon
    Humberto Govea-Camacho, Luis
    Cruz, Alvaro
    Francisco Munoz-Valle, Jose
    Jesus Bustos-Rodriguez, Felipe
    Laura Pereira-Suarez, Ana
    Azucena Palafox-Sanchez, Claudia
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 2053 - 2060
  • [40] The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies
    K H Shain
    J Tao
    Oncogene, 2014, 33 : 4107 - 4113